NovaBridge Biosciences (NBP) Assets Average (2020 - 2025)

NovaBridge Biosciences (NBP) has 6 years of Assets Average data on file, last reported at $269.0 million in Q4 2025.

• Quarterly Assets Average rose 20.79% year-over-year to $269.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $269.0 million (up 20.79% YoY) and the FY2025 annual result came in at $236.6 million, down 18.66% from the prior year.
• Assets Average advanced to $269.0 million in Q4 2025 per NBP's latest filing, from $242.1 million in the prior quarter.
• Across five years, Assets Average topped out at $954.0 million in Q2 2021 and bottomed at $207.8 million in Q2 2025.
• The 5-year median for Assets Average is $269.0 million (2025), against an average of $478.4 million.
• The widest annual swing landed in 2021, when Assets Average jumped 255.62%; it then tumbled 34.8% in 2023.
• Tracing NBP's Assets Average over 5 years: stood at $914.1 million in 2021, then declined by 27.91% to $659.0 million in 2022, then fell by 19.8% to $528.5 million in 2023, then tumbled by 57.87% to $222.7 million in 2024, then advanced by 20.79% to $269.0 million in 2025.
• Per Business Quant, the three latest NBP Assets Average figures stand at $269.0 million (Q4 2025), $242.1 million (Q3 2025), and $207.8 million (Q2 2025).

Peer Comparison